C12N 2015/8536
Animal models for genetic diseases
Official title: {Animal models for genetic diseases}
C12N2015/8536 (Animal models for genetic diseases) appears on 48 US grants and 90 published applications in this corpus.
Search patents in C12N- Granted patents
- 48
- Published applications
- 90
- Assignees
- 69
- Inventors
- 212
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 2 | 4 |
| 2015 | 1 | 2 |
| 2016 | 3 | 7 |
| 2017 | 5 | 8 |
| 2018 | 3 | 13 |
| 2019 | 4 | 9 |
| 2020 | 3 | 5 |
| 2021 | 6 | 8 |
| 2022 | 6 | 7 |
| 2023 | 5 | 8 |
| 2024 | 2 | 6 |
| 2025 | 3 | 4 |
| 2026 | 4 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of treatment with aminolevulinic acid synthase 2 (ALAS2) modulators30 Jun 2026US 12,667,087 B2Agios Pharmaceuticals, Inc.
- Exon-humanized mouse30 Jun 2026US 12,668,810 B2Transgenic Inc.
- Single chain fusionconstructs comprising multimeric antibody fragments fused to collagen trimerization domains17 Feb 2026US 12,552,867 B2Leadartis, S.L.
- Dwarfism animal model having IGF-1 genetic mutation and method for producing same3 Feb 2026US 12,538,904 B2Korea Research Institute of Bioscience and Biotechnology
- Transgenic animal phenotyping platform and uses thereof18 Nov 2025US 12,471,580 B2InVivo Biosystems, Inc.
- Dystonia mouse models with overt dystonia11 Jun 2026US 2026/0157352 A1University of Florida Research Foundation, Inc.
- Transgenic animal phenotyping platform and uses thereof16 Oct 2025US 2025/0318509 A1InVivo Biosystems, Inc.
- Method of genetic manipulation of neural cells in gyrencephalic fetal brain and uses thereof9 Oct 2025US 2025/0311705 A1Children's National Medical Center
- A rodent model of fibrodysplasia ossificans progressiva25 Sep 2025US 2025/0295096 A1
- Humanized M-CSF Mice6 Mar 2025US 2025/0072406 A1Institute for Research in Biomedicine (IRB)
Most cited
By later US patents
- Humanized M-CSF mice24US 8,847,004 B2Institute for Research in Biomedicine (IRB) · 2014
- Humanized M-CSF mice21US 9,655,352 B2Institute for Research in Biomedicine (IRB) · 2017
- Ungulates with genetically modified immune systems12US 9,585,374 B2Revivicor, Inc. · 2017
- Methods and materials for producing transgenic artiodactyls10US 8,518,701 B2Recombinetics, Inc. · 2013
- Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes10US 8,722,964 B2Transposagen Biopharmaceuticals, Inc. · 2014